ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors
pharmaceutical-technology
September 06, 2018Sartorius Stedim Biotech and Repligen Corporation have entered into a collaboration agreement to integrate Repligen’s XCell? ATF cell retention control technology into SSB’s BIOSTAT? STR large-scale single-use bioreactors to create novel perfusion-enabled
Pharma Sources Insight January 2025
